01 334BOEHRINGER INGELHEIM
01 1610258637*PED
02 410596120*PED
03 410610489*PED
04 211033552*PED
05 1611090323*PED
06 67407955
07 67407955*PED
08 167579449
09 167579449*PED
10 167713938
11 167713938*PED
12 88551957
13 88551957*PED
14 28673927
15 28673927*PED
16 68883805
17 49155705
18 29173859
19 49415016
20 209949997
21 129949998
22 410022379
23 1610258637
24 410406172
25 1610596120
26 410610489
27 211033552
28 1611090323
29 311564886
30 111666590
31 611813275
32 3211833166
33 1612115179
34 212178819
35 68883805*PED
36 109949997*PED
37 109949998*PED
01 38Y
02 296Blank
01 79Y
02 255Blank
01 62025-05-02
02 62025-11-02
03 62025-11-26
04 62026-05-26
05 162027-04-15
06 82027-05-04
07 162027-10-15
08 42027-11-04
09 162028-08-01
10 162029-02-01
11 82029-04-02
12 82029-10-14
13 162030-02-11
14 82030-04-14
15 42030-05-21
16 42030-06-15
17 42030-09-30
18 42031-03-30
19 192032-03-07
20 42032-09-07
21 712034-04-03
22 202034-05-17
23 122034-06-11
24 322034-10-03
25 102034-11-17
26 102034-12-11
Patent Expiration Date : 2027-05-04
US Patent Number : 9173859
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1772
Delist Requested : Y
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2027-05-04
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 206073
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-06-11
US Patent Number : 9949998
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-11
Patent Expiration Date : 2034-05-17
US Patent Number : 9949997
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-2292
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-17
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
